Peptide profile
Cerebrolysin
Neurotrophic peptide blend for cognitive repair
Compare Cerebrolysin with other peptides →Summary
Neurotrophic peptide mix for brain repair & cognitive recovery.
- Typical dose
- 5-10mL Daily (5 days/week)
- Route
- Intramuscular
- Cycle length
- 20-30 days
- Evidence
- Animal data
Mechanism
How it works
Cerebrolysin acts like brain fertilizer — it provides the nutrient-rich mixture that helps neurons grow new connections.
Mixture of low-molecular-weight neuropeptides from purified porcine brain mimicking neurotrophic factor activity.
Reported in research
Benefits
- Promotes neurogenesis and synaptogenesis
- Protects against neurodegenerative diseases
- Improves recovery from stroke and TBI
Context, not a prescription
Dosing
- Typical range
- 5-10mL Daily (5 days/week) (Intramuscular)
- Cycle length
- 20-30 days
Safety
Side effects & contraindications
Possible side effects
- Injection site pain
- Mild headache
- Dizziness
- Allergic reaction
- Anxiety
- Agitation
Contraindications
- Epilepsy (seizure threshold)
- Pregnancy or breastfeeding
- Severe renal disease
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Improved cognition, enhanced neuroplasticity, stroke recovery support.
How it works
Cerebrolysin acts like brain fertilizer — it provides the nutrient-rich mixture that helps neurons grow new connections.
Crosses blood-brain barrier and activates neurotrophic signaling pathways.
What to expect
Delayed onset; cognitive improvements by 2-4 weeks.
- Week 1: No immediate effects (delayed onset).
- Weeks 2-3: Early cognitive improvements.
- Weeks 4-6: Neuroprotective and cognitive benefits.
Good to know
- Start with lower dose (2-5mL)
- Monitor for seizure activity
- Use with medical supervision
Staying safe
- Injection site pain
- Mild headache
- Dizziness
Avoid if you have:
- Epilepsy (seizure threshold)
- Pregnancy or breastfeeding
- Severe renal disease
Mechanism of action
Mixture of low-molecular-weight neuropeptides from purified porcine brain mimicking neurotrophic factor activity.
Crosses blood-brain barrier and activates neurotrophic signaling pathways.
Pharmacodynamics
Delayed onset; cognitive improvements by 2-4 weeks.
Improved cognition, enhanced neuroplasticity, stroke recovery support.
Timeline
- Week 1: No immediate effects (delayed onset).
- Weeks 2-3: Early cognitive improvements.
- Weeks 4-6: Neuroprotective and cognitive benefits.
Comparisons
- Cerebrolysin — effectiveness Moderate, safety Good, cost $$$, Hard to use
- Dihexa — effectiveness Emerging, safety Emerging, cost $$, Medium to use
Adverse effects
Common:
- Injection site pain
- Mild headache
- Dizziness
Rare:
- Allergic reaction
- Anxiety
- Agitation
Contraindications & risk mitigation
Contraindicated in:
- Epilepsy (seizure threshold)
- Pregnancy or breastfeeding
- Severe renal disease
- Start with lower dose (2-5mL)
- Monitor for seizure activity
- Use with medical supervision
Qué hace
Mejora de la cognición, mayor neuroplasticidad, apoyo en la recuperación del accidente cerebrovascular.
Cómo funciona
El Cerebrolysin actúa como un fertilizante cerebral: proporciona una mezcla rica en nutrientes que ayuda a las neuronas a formar nuevas conexiones.
Atraviesa la barrera hematoencefálica y activa vías de señalización neurotrófica.
Qué esperar
Inicio retardado; mejoras cognitivas a las 2-4 semanas.
- Semana 1: Sin efectos inmediatos (inicio retardado).
- Semanas 2-3: Mejoras cognitivas iniciales.
- Semanas 4-6: Beneficios neuroprotectores y cognitivos.
Bueno saber
- Comenzar con dosis baja (2-5 mL)
- Vigilar la aparición de convulsiones
- Usar bajo supervisión médica
Manteniéndose seguro
- Dolor en el sitio de inyección
- Dolor de cabeza leve
- Mareos
Evitar si tienes:
- Epilepsia (umbral convulsivo)
- Embarazo o lactancia
- Enfermedad renal grave
Mecanismo de acción
Mezcla de neopéptidos de bajo peso molecular derivados de cerebro porcino purificado que imita la actividad de los factores neurotróficos.
Atraviesa la barrera hematoencefálica y activa vías de señalización neurotrófica.
Farmacodinamia
Inicio retardado; mejoras cognitivas a las 2-4 semanas.
Mejora de la cognición, mayor neuroplasticidad, apoyo en la recuperación del accidente cerebrovascular.
Cronología
- Semana 1: Sin efectos inmediatos (inicio retardado).
- Semanas 2-3: Mejoras cognitivas iniciales.
- Semanas 4-6: Beneficios neuroprotectores y cognitivos.
Comparaciones
- Cerebrolysin — efectividad Moderada, seguridad Buena, costo $$$, Difícil de usar
- Dihexa — efectividad Emergente, seguridad Emergente, costo $$, Media de usar
Efectos adversos
Comunes:
- Dolor en el sitio de inyección
- Dolor de cabeza leve
- Mareos
Raros:
- Reacción alérgica
- Ansiedad
- Agitación
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Epilepsia (umbral convulsivo)
- Embarazo o lactancia
- Enfermedad renal grave
- Comenzar con dosis baja (2-5 mL)
- Vigilar la aparición de convulsiones
- Usar bajo supervisión médica
Reference data
Specifications
- Route
- Intramuscular
- Cycle length
- 20-30 days
FAQ
Common questions
Is Cerebrolysin FDA-approved?
No, it is approved in Europe and Asia for stroke and dementia but not in the US.
What is the evidence level?
This compound is classified as Animal data. Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Research
Research & sources
Current evidence for Cerebrolysin is rated as Animal data. Research is based primarily on animal models.
- 1. Cerebrolysin in stroke (2015) — DOI:10.1161/STROKEAHA.114.008612
- 2. Cerebrolysin in stroke (2015)